Skip to content
Dose Brief
Menu

Kongo review

By Updated

Kongo separates monthly care from discounted first-quarter offers, with explicit regular prices when the promotion ends.

Brief Score69/100Grade CNo. 177 in our directory
Visit Kongo View the provider’s current plans and terms.
Semaglutide

$109/mo monthly option

Regular three-month plan: $285. Eligible first-quarter offer: $190, returning to $285 for the next three-month term.

Full price details

$109/month compounded semaglutide; regular 3-month plan $285 total; limited new-patient code offer $190 for first 3 months

Tirzepatide

$209/mo monthly option

Regular three-month plan: $387. Eligible first-quarter offer: $258, returning to $387 for the next three-month term.

Full price details

$209/month compounded tirzepatide; regular 3-month plan $387 total; limited new-patient code offer $258 for first 3 months

Coverage
Service limited to supported states; confirm individual clinician and pharmacy eligibility
Brand-name
Not confirmed

Prices checked against Kongo's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Monthly options are $109 semaglutide/$209 tirzepatide. First-quarter code offers $190/$258 revert to regular $285/$387 quarterly; eligibility conditions apply.

Kongo in depth

The first-quarter promotion is not the renewal price

Kongo lists monthly compounded semaglutide at $109 and tirzepatide at $209. Regular three-month charges are $285 and $387. The longer-plan equivalents therefore differ from the flexible monthly options. Use the complete payment and supplied quantity when comparing the service with a month-to-month provider.

Limited new-patient codes advertise $190 for the first three months of semaglutide or $258 for tirzepatide. Their offer terms say the next three-month period returns to $285 or $387 unless the plan changes or ends. Lttl is a useful comparison here: it publishes a month-to-month price alongside its prepaid tiers, and its first-month specials also revert to the standing monthly price at the next refill. The billing guide helps separate introductory savings from continuing costs.

Included clinical review and pharmacy fulfillment

The plans describe provider evaluation, clinical messaging and shipping. A licensed prescriber decides whether treatment is appropriate; compounded medications are not FDA-approved. The promotional terms say patients are not charged for medication if the provider determines it is inappropriate. That medication-specific protection does not settle whether every professional-service charge is refundable.

Kongo’s terms identify it as the platform and name AbsoluteRX and Strive among pharmacy partners. Those names do not establish the pharmacy assigned to your prescription or a complete current state roster. Confirm both using the pharmacy verification guide; a national-looking website is not proof of universal prescription availability.

Confirm cancellation and retained consultation charges

The offer is limited to a new patient’s first qualifying three-month order and cannot be combined with other promotions. Kongo may end or change it. Obtain confirmation of the selected charge, next renewal and cancellation method before paying; a code appearing on a public page does not establish that every patient qualifies.

General terms describe consultation fees as nonrefundable and prescription sales as final, while the offer separately protects medically inappropriate medication charges. Ask where cancellation becomes unavailable and which service amounts could remain payable. The refund checklist helps clarify those differences before committing to a quarterly purchase.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Kongo scored on our six Brief Score factors. See the methodology.

Price Stability52/100
Supply Reliability85/100
Transparency40/100
Access Breadth90/100
Clinical Oversight75/100
Track Record87/100

What we like

  • Publishes full introductory and regular quarterly charges
  • Clearly limits promotional codes to new patients
  • Includes provider evaluation, messaging and shipping

The caveats

  • Promotional prices increase after the first quarter
  • Medication-specific state access requires confirmation
  • General terms exclude consultation fees from refunds

The brief

Best for: Readers comparing a shorter monthly option with a first-quarter promotion who can confirm renewal and cancellation terms. Kongo separates monthly care from discounted first-quarter offers, with explicit regular prices when the promotion ends.

Ranked #177 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Kongo.

Closest here

The providers scoring nearest Kongo — read each current assessment before choosing care.

Weighing Kongo against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Kongo, and every provider that outranks it is listed on the Kongo alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Kongo's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Kongo's site. Not medical advice; see our disclosure.

← Back to all rankings